NOV (NOV) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for May 20, 2025, at company headquarters in Houston, TX.
Shareholders are invited to vote on key proposals, including director elections and executive compensation.
Voting can be completed online, by mail, or in person, with deadlines specified for each method.
Voting matters and shareholder proposals
Election of nine director nominees for a one-year term is on the agenda.
Ratification of Ernst & Young LLP as independent auditors for 2025 is proposed.
Advisory vote on executive compensation for named executive officers is included.
Amendment and restatement of the Long-Term Incentive Plan is up for approval.
Other business may be addressed as appropriate during the meeting.
Board of directors and corporate governance
Nine individuals are nominated for election to the board, each for a one-year term.
Latest events from NOV
- 2025 saw strong cash flow and shareholder returns despite lower revenue and a cautious 2026 outlook.NOV
Q4 20255 Feb 2026 - Q2 2024 revenue up 6% to $2.22B, with record backlog and higher shareholder returns.NOV
Q2 20242 Feb 2026 - Adjusted EBITDA and cash flow rose despite lower revenue, with strong capital returns and backlog.NOV
Q1 202519 Jan 2026 - Q3 net income up 14% to $130M, with strong offshore demand and record backlog.NOV
Q3 202418 Jan 2026 - 2024 delivered strong growth, cash flow, and backlog; 2025 outlook is flat revenue, higher margins.NOV
Q4 20249 Dec 2025 - Proxy seeks approval for director elections, auditor, executive pay, and expanded equity plan.NOV
Proxy Filing1 Dec 2025 - Q2 2025 revenue up 4% sequentially; margins pressured, but cash flow and contract wins strong.NOV
Q2 20253 Nov 2025 - Q3 2025 saw lower earnings but strong bookings, free cash flow, and record backlog.NOV
Q3 202529 Oct 2025